We could not find any results for:
Make sure your spelling is correct or try broadening your search.
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, April 14, 2023 VANCOUVER, BC, April 14, 2023 /CNW/ - TSX VENTURE COMPANIES BULLETIN TYPE: Cease Trade...
Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference Canada NewsWire CALGARY, AB, May 13, 2022 CALGARY, AB, May 13, 2022 /CNW/ - Universal Ibogaine...
UNIVERSAL IBOGAINE RETAINS SHAYNE NYQUVEST AS CAPITAL MARKETS ADVISOR Canada NewsWire CALGARY, AB, April 29, 2022 CALGARY, AB, April 29, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB:...
UNIVERSAL IBOGAINE PROVIDES UPDATE ON KELBURN RECOVERY CENTER OPERATIONS Canada NewsWire CALGARY, AB, April 7, 2022 CALGARY, AB, April 7, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO...
Universal Ibogaine Announces Frankfurt Stock Exchange Listing Canada NewsWire CALGARY, AB, April 6, 2022 CALGARY, AB, April 6, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF...
Universal Ibogaine to Participate in the 2022 Virtual Growth Conference - Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT Canada...
UNIVERSAL IBOGAINE EXPANDS RESEARCH TEAM WITH JULIE DUMOUCHEL, DIRECTOR OF CLINICAL TRIALS Canada NewsWire CALGARY, AB, March 23, 2022 CALGARY, AB, March 23, 2022 /CNW/ - Universal Ibogaine Inc...
CALGARY, Alberta, March 08, 2022 (GLOBE NEWSWIRE) -- Universal Ibogaine (OTCQB:IBOGF) (TSX-V:IBO) (FSE:JC4), a life sciences company based in Canada, focused on transforming the addiction...
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Investor...
Universal Ibogaine Announces Approval for Trading on the OTCQB Venture Market Canada NewsWire CALGARY, AB, Feb. 28, 2022 CALGARY, AB, Feb. 28, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV:IBO...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions